Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Neurelis Announces FDA Approval for Immediate Use Seizure Medication Valtoco (diazepam nasal spray) in Ages 2 to 5 Years

San Diego, CA – April, 16, 2025 – Neurelis, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Valtoco (diazepam...

Mirum’s Livmarli Now FDA Approved in Tablet Formulation

(BUSINESS WIRE) April 14, 2025 -- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved...

FDA Grants Interchangeable Designation to Yuflyma (adalimumab-aaty), Celltrion's Biosimilar to Humira (adalimumab)

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated Yuflyma (adalimumab-aaty), as an interchangeable biosimilar...

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

(BUSINESS WIRE) April 11, 2025 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Opdivo®...

FDA Approves Jobevne (bevacizumab-nwgd), a Biosimilar to Avastin

BRIDGEWATER, New Jersey and BENGALURU, Karnataka, India, April 10, 2025 -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE:...

WHO Announces Completion of Draft Pandemic Agreement

Member states of the World Health Organization forged a draft agreement seeking to strengthen global collaboration on future pandemic prevention, preparedness,...

Digital Technology Linked to Lower Rates of Cognitive Decline in Adults Older Than 50

Widespread use of digital technology seems to be associated with lower rates of cognitive decline in adults older than 50 years, according to a study published...

Study Sheds Light on Role of Risk Factors in Young-Onset Cryptogenic Ischemic Stroke

Traditional risk factors contribute to young-onset cryptogenic ischemic stroke (CIS) without patent foramen ovale (PFO), while nontraditional risk factors...

CT Exams in 2023 Projected to Result in 103,000 Future Cancers

At current utilization and radiation dose levels, computed tomography (CT) examinations in 2023 were projected to result in about 103,000 future cancers...

Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya

THURSDAY, April 17, 2025 — A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including respiratory...

Yoga May Aid Knee Osteoarthritis Pain

Yoga is noninferior to strengthening exercises for knee osteoarthritis (OA) pain in people aged 40 years and older, according to a study published online...

New Endangered Species Rule Would No Longer Count Habitat Loss as 'Harm'

THURSDAY, April 17, 2025 — The Trump administration is proposing a major change to the Endangered Species Act that would no longer deem habitat destruction...

Fewer Americans Traveled for Abortions in 2024, Report Finds

THURSDAY, April 17, 2025 — Fewer Americans traveled out of state for an abortion in 2024, according to a new report from the Guttmacher Institute,...

Orforglipron Demonstrated Statistically Significant Efficacy Results and a Safety Profile Consistent with Injectable GLP-1 Medicines in Successful Phase 3 Trial

Eli Lilly and Company (NYSE: LLY) today announced positive topline Phase 3 results from ACHIEVE-1, evaluating the safety and efficacy of orforglipron compared...

Repurposing Blood Pressure Drug Reserpine May Prevent Vision Loss in Inherited Blinding Diseases

New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy...

FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide) Found in U.S. Drug Supply Chain

FDA was notified by Novo Nordisk on April 3, 2025, that several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg were in the U.S. drug...

How Savvy Habits May Help Head Off Dementia

From slurping daily spoonfuls of fish oil to giving up alcohol, lifting weights and playing word games, older Americans think just about anything that...

Read more news...

Recently Added

Recently added consumer and prescribing information: Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten, Aucatzyl

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Jobevne Jobevne (bevacizumab-nwgd) is a vascular endothelial growth factor inhibitor biosimilar to Avastin used for the treatment of colorectal...
  • Vanrafia Vanrafia (atrasentan) is an endothelin A receptor antagonist used for proteinuria reduction in primary immunoglobulin (IgA) nephropathy.
  • Qfitlia Qfitlia (fitusiran) is an antithrombin-directed small interfering ribonucleic acid for the prophylactic treatment of people with hemophilia...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...

More drugs in development